Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial of recombinant interferon gamma in soft tissue sarcoma (myxoid liposarcoma, round cell liposarcoma, synovial sarcoma) has been terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon gamma recombinant (Interferon gamma)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Myxoid Liposarcoma, Round Cell Liposarcoma | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2019-07-10